Combi-TED evaluates the OSE2101 neo-epitope cancer vaccine with docetaxel or nivolumab after first-line chemo-immunotherapy ...
Results of a New York Times/Philadelphia Inquirer/Siena poll conducted among 404 voters from Oct. 16 to 22, 2026.
Results of New York Times/Philadelphia Inquirer/Siena polls conducted among 1,607 voters from Oct. 16 to 22, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results